ChEMBL is a manually curated database of bioactive molecules with drug-like properties. It brings together chemical, bioactivity and genomic data to aid the translation of genomic information into effective new drugs.
Explore ChEMBL
Description: Shows a summary of the ChEMBL entities and quantities of data for each of them.
Instructions: Click on a bubble to explore a specific ChEMBL entity in more detail.
Current Release:
Provided under a
Creative Commons Attribution-ShareAlike 3.0 Unported license
Citing ChEMBL
The ChEMBL Database in 2023: a drug discovery platform spanning
multiple bioactivity data types and time periods.
ChEMBL web services: streamlining access to drug discovery data and utilities.
Barbara Zdrazil, Boy Felix, Fiona Hunter, Emma J Manners, James
Blackshaw, Sybilla Corbett, Marleen de Veij, Harris Ioannidis,
David Mendez Lopez, Juan F Mosquera, Maria Paula Magarinos,
Nicolas Bosc, Ricardo Arcila, Tevik Kizilören, Anna Gaulton, A
Patrícia Bento, Melissa. F Adasme, Pater Monecke, Gregory A
Landrum, Andrew R Leach
- Nucleic Acids Res. 2023: gkad1004. doi: 10.1093/nar/gkad1004
ChEMBL web services: streamlining access to drug discovery data and utilities.
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F,
Bellis L, Overington JP.
- Nucleic Acids Res. 2015; 43(W1):W612-20, doi:
10.1093/nar/gkv352
Associated Resources
In addition to the database, we have developed a series of thematic portals to the underlying ChEMBL data for users with a particular focus to their research
ChEMBL is part of the ELIXIR infrastructure
ChEMBL is and Elixir Core Data Resource
Learn More
ChEMBL is a Global Core Biodata Resource